Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO) -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (2595)	12/24/1998 11:17:00 AM
From: Stefan Habermayer	Read Replies (1) \| Respond to of 2615

Really bad news: 17.5 Mill USD LOSS - how is this possible ? Luis, I wished it would be a "better news" - but this is really too bad ... Regards, Stefan ===================================================================== Wednesday December 23, 5:23 pm Eastern Time Caprius says auditors may doubt continuance WILMINGTON, Mass., Dec 23 (Reuters) - Imaging systems maker Caprius Inc. on Wednesday said auditors are likely to have doubts about the whether the company can continue to do business, if it is unable to find a buyer for its Aurora imaging technology. Caprius on Wednesday reported a fiscal 1998 net loss of $17.5 million, or $2.49 a share. Losses included two non-cash charges of $7 million for purchased research and development related to its merger with Advanced Mammography Systems, and a $1.9 million for the writedown of intangibles related to its rehabilitation business. Chairman and Chief Executive Jack Nelson said in a statement that Caprius would continue to try to sell or find a partner for its Aurora technology. Caprius describes Aurora as the only dedicated breast magnetic-resonance-based imaging system that has been cleared by the U.S. Food and Drug Administration. The company said its auditor's report to be released on Jan. 13 on the year ended Sept. 30, 1998 may describe its ability to stay in business as a going concern, if it fails to sell or find a buyer for its Aurora technology. =====================================================================